3-D Sys Corp Del Stock Price, News & Analysis

3D Systems (NYSE:DDD) has scheduled its second quarter 2025 financial results announcement for Monday, August 11, 2025, after market close. The company will host a conference call and webcast to discuss the results on Tuesday, August 12, 2025, at 8:30 a.m. Eastern Time.

Investors can access the conference call via telephone at 201-689-8345 or listen to the webcast through the company's investor relations website. A replay of the webcast will be available approximately two hours after the conference call concludes.

3D Systems (NYSE:DDD) has announced the full commercial release of its FDA-cleared NextDent® Jetted Denture Solution for the U.S. market. The groundbreaking solution features the new NextDent 300 MultiJet 3D printer and proprietary materials that enable single-piece, multi-material denture production with no post-curing requirements.

The solution delivers 300% faster production compared to traditional methods and 120% faster than existing resin printers. Key innovations include FDA-cleared NextDent® Jet Teeth and NextDent® Jet Base materials, offering superior aesthetics and breakage resistance. The U.S. dental replacement market is projected to reach $600 million by 2029, representing one-third of the global market opportunity.

Initial shipments are scheduled for August 2025, with European and Asian releases pending regulatory approvals. Beta testing has received strong endorsements from leading dental labs, highlighting significant improvements in efficiency, cost-effectiveness, and product quality.

3D Systems (NYSE:DDD) has achieved a significant milestone in regenerative medicine as its bioprinting technologies enabled FDA De Novo marketing authorization for a first-of-its-kind peripheral nerve repair solution. The company collaborated with French MedTech firm TISSIUM to develop COAPTIUM® CONNECT with TISSIUM Light, a bioabsorbable 3D-printed medical device utilizing unique photopolymer technology.

This breakthrough combines TISSIUM's biomorphic programmable polymers with 3D Systems' bioprinting expertise to create high-resolution, elastomeric biodegradable implants. The development builds on 3D Systems' nearly decade-long leadership in bioprinting, including its collaboration with United Therapeutics Corporation for human lung development. The global bioprinting market is projected to grow from $1.3 billion in 2024 to $2.4 billion by 2029.

3D Systems (NYSE:DDD) has announced significant balance sheet improvements through strategic financial transactions. The company has successfully retired $88 million of debt (41% of prior balance) at a discount to par value and refinanced with $92 million in new Convertible Senior Secured Notes due 2030. Additionally, DDD has repurchased 8 million shares (approximately 6% of outstanding common stock) to reduce dilution.

Following these transactions, DDD's balance sheet will include $35 million in existing notes due 2026, $92 million in new notes due 2030, and approximately $140 million in cash reserves. The new notes will bear interest at 5.875% per annum and are convertible at a 20% premium to the June 17, 2025 closing price.

3D Systems (NYSE: DDD) has announced the issuance of $92 million in 5.875% convertible senior secured notes due 2030, with closing expected on June 23, 2025. The notes will be convertible into cash, common stock, or a combination at an initial conversion price of $2.24 per share, representing a 20% premium over the current stock price of $1.87. The company will use the proceeds, along with $78 million in cash, to repurchase approximately $180 million of its existing 0% convertible notes due 2026. Additionally, 3D Systems will use $15 million to repurchase about 8 million shares of common stock at $1.87 per share. The new notes include provisions for holder conversion rights, a one-time put option in 2028, and company redemption options after June 20, 2028.

3D Systems (NYSE: DDD) announced collaborations with Penn State University and Arizona State University on NASA-sponsored projects to develop advanced thermal management solutions for spacecraft. The teams successfully created innovative heat pipe radiators using 3D Systems' Direct Metal Printing technology and Oqton's 3DXpert software. Key achievements include titanium heat pipe radiators that are 50% lighter and operate at 230°C, and one of the first additively manufactured shape memory alloy radiators using nitinol, offering a 6× larger deployed-to-stowed area ratio than current solutions. These innovations help manage severe temperature fluctuations in space, prevent component damage, and extend satellite lifespan. The global market for additive manufacturing in aerospace is projected to reach $3.8 billion by 2030, with 3D Systems having already contributed to over 2,000 structural components and 200 RF flight parts.

3D Systems (NYSE:DDD) reported Q1 2025 financial results with revenue of $94.5 million, down 8% year-over-year. The company faced challenges with net loss widening to $37 million ($0.28 per share) compared to $16 million loss in Q1 2024. Key highlights include: - Healthcare Solutions revenue declined 9% to $41.3 million - Industrial Solutions revenue decreased 7% to $53.2 million - Gross profit margin dropped to 34.6% from 39.8% - Company withdrew full-year 2025 guidance due to weak customer capital spending On the positive side, 3D Systems strengthened its balance sheet through the sale of Geomagic portfolio, adding over $100 million post-tax to cash reserves, reaching approximately $250 million by April 30, 2025. The company is implementing cost-saving initiatives, including a $50 million program scheduled for completion by mid-2026 and an additional $20 million cost reduction plan for 2025.

3D Systems (NYSE: DDD) is advancing digital dentistry with its NextDent® material portfolio, which addresses over 30 dental applications. The company's solutions focus on patient-specific devices for straightening, protecting, repairing, and replacing teeth. Their NextDent materials, compatible with NextDent 5100 and LCD1 printers, as well as other leading dental 3D printers, have received regulatory approvals across the US, Europe, and Asia.

The company's dental 'repair' market is projected to reach $150 million by 2029 in the US alone, representing one-third of the global market. Combined with other dental segments, the total US market opportunity is estimated at nearly $1 billion. Key materials include NextDent C&B MFH for crowns and bridges, and CROWNTEC™ through a partnership with Saremco Dental AG. 3D Systems' digital dentistry solutions have already served more than one million patients.

3D Systems (NYSE:DDD) has scheduled the release of its first quarter 2025 financial results after U.S. market hours on Monday, May 12, 2025.

The company will host a conference call and simultaneous webcast to discuss these results on Tuesday, May 13, 2025, at 8:30 a.m. Eastern Time. Investors and interested parties can participate through two channels:

• Webcast: Available at www.3dsystems.com/investor
• Telephone: Dial-in number 201-689-8345

A replay of the webcast will be made available approximately two hours after the conference call concludes, accessible through the company's investor relations website.